{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T23:21:01Z","timestamp":1774048861379,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.intimp.2013.02.013","type":"journal-article","created":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T20:56:23Z","timestamp":1363294583000},"page":"772-779","source":"Crossref","is-referenced-by-count":18,"title":["Chromone linked nitrone derivative induces the expression of iNOS2 and Th1 cytokines but reduces the Th2 response in experimental visceral leishmaniasis"],"prefix":"10.1016","volume":"15","author":[{"given":"Suvadip","family":"Mallick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhadra","family":"Halder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aritri","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somaditya","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kausik","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sourav","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrakanta","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaskar","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiranjib","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2013.02.013_bb0005","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.intimp.2013.02.013_bb0010","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrmicro981","article-title":"Leishmaniasis","volume":"2","author":"Desjeux","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.intimp.2013.02.013_bb0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijantimicag.2007.05.007","article-title":"Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo","volume":"3","author":"Seifert","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.intimp.2013.02.013_bb0020","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4269\/ajtmh.2009.80.580","article-title":"Relapse of visceral leishmaniasis after miltefosine treatment in a Nepalese patient","volume":"80","author":"Pandey","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.intimp.2013.02.013_bb0025","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1021\/jm060359j","volume":"49","author":"Vasselin","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.intimp.2013.02.013_bb0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/157340710791184859","article-title":"Bioactive chromone derivatives \u2014 structural diversity","volume":"6","author":"Machado","year":"2010","journal-title":"Curr Bioact Compd"},{"key":"10.1016\/j.intimp.2013.02.013_bb0035","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1021\/jm058208o","article-title":"Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives","volume":"48","author":"Dominguez","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.intimp.2013.02.013_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2003.10.003","article-title":"Inhibition of the development of hepatocellular carcinomas by phenyl N-tert-butyl nitrone in rats fed with a choline-deficient, L-amino acid-defined diet","volume":"206","author":"Nakae","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1016\/j.intimp.2013.02.013_bb0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10715769509064017","article-title":"Alpha-phenyl N-tert-butyl nitrone (Pbn) increases the cortical cerebral blood flow by inhibiting the breakdown of nitric oxide in anesthetized rats","volume":"23","author":"Inanami","year":"1995","journal-title":"Free Radic Res"},{"key":"10.1016\/j.intimp.2013.02.013_bb0050","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.144.12.4794","article-title":"Macrophage killing of leishmania parasite in vivo is mediated by nitric oxide from L-arginine","volume":"144","author":"Liew","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.02.013_bb0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/375408a0","article-title":"Altered immune responses in mice lacking inducible nitric oxide synthase","volume":"375","author":"Wei","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2013.02.013_bb0060","first-page":"473","article-title":"Induction of macrophage killing of Leishmania donovani by human CD4+ T cell clones","volume":"27","author":"Melby","year":"1996","journal-title":"Arch Med Res"},{"key":"10.1016\/j.intimp.2013.02.013_bb0065","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.4049\/jimmunol.138.7.2290","article-title":"Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma","volume":"138","author":"Murray","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.02.013_bb0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpara.2004.10.018","article-title":"Leishmania inhibits STAT1-mediated IFN-\u03b3 signaling in macrophages: increased tyrosine phosphorylation of dominant negative STAT1 by Leishmania mexicana","volume":"35","author":"Bhardwaj","year":"2005","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.intimp.2013.02.013_bb0075","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/eji.1830250913","article-title":"Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmnia-infected macrophages and its implication in the suppression of cell-mediated immunity","volume":"25","author":"Saha","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2013.02.013_bb0080","first-page":"238","article-title":"Immune response to leishmania infection","volume":"119","author":"Awasthi","year":"2004","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.intimp.2013.02.013_bb0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.parint.2005.01.001","article-title":"Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis","volume":"54","author":"Dutta","year":"2005","journal-title":"Parasitol Int"},{"key":"10.1016\/j.intimp.2013.02.013_bb0090","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0968-0896(02)00046-9","article-title":"Synthesis of 2-(2-methyl-quinolin-4-ylamino)-N-phenyl acetamide: a potential antileishmanial drug","volume":"10","author":"Sahu","year":"2002","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.intimp.2013.02.013_bb0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1550-7408.1958.tb02565.x","article-title":"An eight-day method for screening compounds against Leishmania donovani in golden hamster","volume":"5","author":"Stauber","year":"1958","journal-title":"J Protozool"},{"key":"10.1016\/j.intimp.2013.02.013_bb0100","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.4049\/jimmunol.170.11.5625","article-title":"Dendritic cell-based immunotherapy combined with antimony-based chemotherapy cures established murine visceral leishmaniasis","volume":"170","author":"Ghosh","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.02.013_bb0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jac\/dkn479","article-title":"Quassin alters the immunological patterns of murine mac rophages through generation of nitric oxide to exert antileishmanial activity","volume":"63","author":"Bhattacharjee","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.intimp.2013.02.013_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0009252","article-title":"Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile","volume":"5","author":"Maggini","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2013.02.013_bb0115","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1128\/IAI.70.10.5651-5658.2002","article-title":"Interleukin-4 receptor \u03b1 chain and STAT6 signaling inhibit gamma interferon but not Th2 cytokine expression within schistosome granulomas","volume":"70","author":"Metwali","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2013.02.013_bb0120","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/AAC.50.5.1788-1797.2006","article-title":"Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani \u2014 infected macrophages","volume":"50","author":"Basu","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.intimp.2013.02.013_bb0125","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1128\/IAI.00490-08","article-title":"Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice","volume":"76","author":"Murray","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2013.02.013_bb0130","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.4049\/jimmunol.0803859","article-title":"Miltefosine promotes IFN-\u03b3-dominated anti-leishmanial immune response","volume":"182","author":"Wadhone","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.02.013_bb0135","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.4049\/jimmunol.167.6.3391","article-title":"Sodium stibogluclonate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines","volume":"167","author":"Pathak","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.02.013_bb0140","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000330856","article-title":"Protective therapy with novel chromone derivative against Leishmania donovani infection induces Th1 response in vivo","volume":"57","author":"Mallick","year":"2011","journal-title":"Chemotherapy"},{"key":"10.1016\/j.intimp.2013.02.013_bb0145","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1084\/jem.185.7.1231","article-title":"Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice","volume":"185","author":"Taylor","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.02.013_bb0150","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/ni1539","article-title":"TGF-\u03b2 and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T-17 cell-mediated pathology","volume":"8","author":"McGeachy","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.02.013_bb0155","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/ni1540","article-title":"Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells","volume":"8","author":"Fitzgerald","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.02.013_bb0160","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/ni1537","article-title":"Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10","volume":"8","author":"Stumhofer","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.02.013_bb0165","first-page":"407","article-title":"Antimicrobial mechanisms of macrophages","volume":"5","author":"Shiloh","year":"1999"},{"key":"10.1016\/j.intimp.2013.02.013_bb0170","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1128\/IAI.65.5.1675-1682.1997","article-title":"Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii","volume":"65","author":"Neyer","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2013.02.013_bb0175","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1172\/JCI116570","article-title":"Interleukin 10 production correlates with pathology in human Leishmania donovani infections","volume":"92","author":"Ghalib","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2013.02.013_bb0180","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.4049\/jimmunol.158.7.3311","article-title":"IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi","volume":"158","author":"Hunter","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.02.013_bb0185","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","article-title":"Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis","volume":"146","author":"Kaye","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.02.013_bb0190","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.166.2.1141","article-title":"The role of IL-10 in promoting disease progression in leishmaniasis","volume":"166","author":"Kane","year":"2001","journal-title":"J Immunol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913000556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913000556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T09:00:54Z","timestamp":1688115654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576913000556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1567576913000556"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2013.02.013","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}